# A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients

> **NCT01478607** · PHASE3 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 468 (actual)

## Conditions studied

- Painful Diabetic Peripheral Neuropathy (PDPN)

## Interventions

- **DRUG:** QUTENZA

## Key facts

- **NCT ID:** NCT01478607
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 468 (ACTUAL)
- **Last updated:** 2015-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01478607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01478607, "A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01478607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*